CavitySpace: A Database of Potential Ligand Binding Sites in the Human Proteome.
PMID:35883523
Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2.
PMID:35859885
RET kinase inhibitors for RET-altered thyroid cancers.
PMID:35756966
Deciphering the conformational transitions of LIMK2 active and inactive states to ponder specific druggable states through microsecond scale molecular dynamics simulation.
PMID:35652973
Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers.
PMID:35598228
Design, synthesis, and bioactivity evaluation of antitumor sorafenib analogues.
PMID:35558629
TeachOpenCADD 2022: open source and FAIR Python pipelines to assist in structural bioinformatics and cheminformatics research.
PMID:35524571
Regulatory spine RS3 residue of protein kinases: a lipophilic bystander or a decisive element in the small-molecule kinase inhibitor binding?
PMID:35226061
Profiling MAP kinase cysteines for targeted covalent inhibitor design.
PMID:35224496
A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations.
PMID:34948218
Synthesis, In Vitro and In Silico Anticancer Activity of New 4-Methylbenzamide Derivatives Containing 2,6-Substituted Purines as Potential Protein Kinases Inhibitors.
PMID:34884546
Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation.
PMID:34827669
In Pursuit of an Allosteric Human Tropomyosin Kinase A (hTrkA) Inhibitor for Chronic Pain.
PMID:34795875
Reactivities of the Front Pocket N-Terminal Cap Cysteines in Human Kinases.
PMID:34647463
Kincore: a web resource for structural classification of protein kinases and their inhibitors.
PMID:34643709
Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment.
PMID:34361615
Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema.
PMID:34359853
Aromatic Rings as Molecular Determinants for the Molecular Recognition of Protein Kinase Inhibitors.
PMID:33810025
Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR).
PMID:33670650
Data set of competitive and allosteric protein kinase inhibitors confirmed by X-ray crystallography.
PMID:33604432
Analyzing Kinase Similarity in Small Molecule and Protein Structural Space to Explore the Limits of Multi-Target Screening.
PMID:33530327
Prediction of kinase inhibitors binding modes with machine learning and reduced descriptor sets.
PMID:33436888
Assessing the information content of structural and protein-ligand interaction representations for the classification of kinase inhibitor binding modes via machine learning and active learning.
PMID:33431025
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.
PMID:33410674
Nanomedicine of tyrosine kinase inhibitors.
PMID:33408767
Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.
PMID:33161056
Diversity of Long-Lived Intermediates along the Binding Pathway of Imatinib to Abl Kinase Revealed by MD Simulations.
PMID:33147951
Is Structure-Based Drug Design Ready for Selectivity Optimization?
PMID:33119284
KLIFS: an overhaul after the first 5 years of supporting kinase research.
PMID:33084889
Inhibitors of BRAF dimers using an allosteric site.
PMID:32873792
Using phosphoproteomics data to understand cellular signaling: a comprehensive guide to bioinformatics resources.
PMID:32676006
Proposing the Promiscuous Protein Structures in JNK1 and JNK3 for Virtual Screening in Pursuit of Potential Leads.
PMID:32149224
Identification of Druggable Kinase Target Conformations Using Markov Model Metastable States Analysis of apo-Abl.
PMID:31999924
A Structurally-Validated Multiple Sequence Alignment of 497 Human Protein Kinase Domains.
PMID:31875044
Advances in MS Based Strategies for Probing Ligand-Target Interactions: Focus on Soft Ionization Mass Spectrometric Techniques.
PMID:31709232
Structure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1).
PMID:31531194
How Electrostatic Coupling Enables Conformational Plasticity in a Tyrosine Kinase.
PMID:31476863
Encounter complexes and hidden poses of kinase-inhibitor binding on the free-energy landscape.
PMID:31451651
Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors.
PMID:31129879
Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib.
PMID:31118272
Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors.
PMID:30945531
Defining a new nomenclature for the structures of active and inactive kinases.
PMID:30867294
How to design potent and selective DYRK1B inhibitors? Molecular modeling study.
PMID:30673861
KinaMetrix: a web resource to investigate kinase conformations and inhibitor space.
PMID:30321373
Life beyond the Tanimoto coefficient: similarity measures for interaction fingerprints.
PMID:30288626
Exploring Selectivity of Multikinase Inhibitors across the Human Kinome.
PMID:30221217
Discovery and biological evaluation of N5-substituted 6,7-dioxo-6,7-dihydropteridine derivatives as potent Bruton's tyrosine kinase inhibitors.
PMID:30108960
Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors.
PMID:29937490
A molecular dynamics investigation of CDK8/CycC and ligand binding: conformational flexibility and implication in drug discovery.
PMID:29737445
Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis.
PMID:29514601
Prediction of Protein-compound Binding Energies from Known Activity Data: Docking-score-based Method and its Applications.
PMID:29442436
3D-e-Chem: Structural Cheminformatics Workflows for Computer-Aided Drug Discovery.
PMID:29337438
Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase.
PMID:29072804
Determining Cysteines Available for Covalent Inhibition Across the Human Kinome.
PMID:28326775
Classifying kinase conformations using a machine learning approach.
PMID:28152981
3D-e-Chem-VM: Structural Cheminformatics Research Infrastructure in a Freely Available Virtual Machine.
PMID:28125221
Quantitative Structure-activity Relationship (QSAR) Models for Docking Score Correction.
PMID:28001004
Structural propensities of kinase family proteins from a Potts model of residue co-variation.
PMID:27241634
Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach.
PMID:26929980
Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity.
PMID:26895387
Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging.
PMID:26690113
KLIFS: a structural kinase-ligand interaction database.
PMID:26496949
p38α MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening.
PMID:26334265
Navigating into the binding pockets of the HER family protein kinases: discovery of novel EGFR inhibitor as antitumor agent.
PMID:26229444
Fragment virtual screening based on Bayesian categorization for discovering novel VEGFR-2 scaffolds.
PMID:26022686
Specificity rendering 'hot-spots' for aurora kinase inhibitor design: the role of non-covalent interactions and conformational transitions.
PMID:25485544
Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors.
PMID:25478866
Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?
PMID:24730530